Adamas Announces New Safety and Efficacy Data for GOCOVRI® in Parkinson’s Disease Patients with Dyskinesia at the Movement Disorder Society 2019 International Congress

September 20, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search